Inspired by the NJ Cannabis Insider Q&A with Satya Capital’s Nishant Reddy, I sat with Jason Erkes, Chief Communications Officer with Cresco Labs, for a closer look at the company’s New Jersey plans.
One of the fastest-growing companies
CannaBiz, published by Chiesa Shahinian & Giantomasi PC, focuses on legal issues surrounding the cannabis industry, particularly in New Jersey. The blog covers regulatory developments, licensing processes for medical marijuana dispensaries, and compliance with state and federal laws. It addresses ethical considerations for attorneys involved in cannabis businesses, expungement reforms related to marijuana convictions, and the challenges of banking and capital for cannabis entrepreneurs. The blog also highlights community reinvestment and social equity initiatives within the cannabis sector. It serves as a resource for legal guidance on cannabis law, policy changes, and industry trends affecting businesses, patients, and legal professionals.
Inspired by the NJ Cannabis Insider Q&A with Satya Capital’s Nishant Reddy, I sat with Jason Erkes, Chief Communications Officer with Cresco Labs, for a closer look at the company’s New Jersey plans.
One of the fastest-growing companies…
I am pleased to share with our subscribers an NJ Cannabis Insider Q&A featuring Nishant Reddy, co-founder of the California-based boutique investment firm Satya Capital. CSG supported Satya as they partnered with MedMen on a joint application to operate…
After a brief hiatus, we welcome you back to CSG’s CannaBiz Law Blog. The August 31stRFA deadline was challenging, but I am pleased to report that an all hands on deck effort on behalf of our clients made for…
On August 10, 2018, the District Court for the District of New Jersey granted an employer’s motion to dismiss a lawsuit for disability discrimination, finding that neither the New Jersey Law Against Discrimination (“NJLAD”) nor the New Jersey Compassionate Use…
On July 16, 2018, the New Jersey Department of Health’s Division of Medicinal Marijuana (the “DOH”) issued a Request for Applications (“RFA”) for up to six additional Alternative Treatment Centers (“ATCs”), commonly referred to as medical marijuana dispensaries. The DOH…
The number of authorized medical marijuana users in New Jersey is growing. According to a 2017 Marist Poll, the number of adult Americans using marijuana is 22%. Thus, employers should not be sitting idle, waiting for the decriminalization of recreational…
While the likely decriminalization of recreational marijuana is all the buzz in New Jersey, employers cannot forget that they need to be prepared now to address an employee who is a medical marijuana card holder under New Jersey’s Compassionate Use…
With the legalization of medical marijuana through New Jersey’s Compassionate Use of Medical Marijuana Act, and the decriminalization of recreational marijuana on the horizon, employers may want to revisit their drug screening policies and consider eliminating testing for marijuana for…
On June 18, 2018, the New Jersey Department of Health (the “DOH”) published for comment its proposed amendments to the administrative regulations to New Jersey’s Medical Marijuana Program (“MMP”). These regulations establish the standards by which the DOH implements the…
On June 7, 2018, Senators Cory Gardner (R-CO) and Elizabeth Warren (D-MA) introduced the Strengthening the Tenth Amendment Through Entrusting States Act (“the STATES Act” or “the Act”) in the Senate. That same day, Representatives Earl Blumenauer (D-OR) and David Joyce…